• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Latest News

SCAN Project Empowers Cosmetologists in Early Skin Cancer Detection
SCAN Project Empowers Cosmetologists in Early Skin Cancer Detection

November 6th 2024

Bree Vanleeuwen, PA-C, and Jim Sutton, PA-C, discussed the Skin Cancer Awareness project—a unique initiative to train cosmetologists and hairdressers to recognize suspicious skin lesions and refer clients for dermatologic evaluation.

Light and Laser Therapy is an Effective Alternative for Alopecia Treatment
Light and Laser Therapy is an Effective Alternative for Alopecia Treatment

November 6th 2024

New Study Underscores High Economic and Comorbidity Burden for Patients with PN
New Study Underscores High Economic and Comorbidity Burden for Patients with PN

November 6th 2024

POLL: Are You Attending the Elevate-Derm West Conference?
POLL: Are You Attending the Elevate-Derm West Conference?

November 6th 2024

Nemolizumab Delivers Rapid Itch Response in Patients with PN
Nemolizumab Delivers Rapid Itch Response in Patients with PN

November 6th 2024

Navigating CSU Diagnosis: Best Practices
Meet the 2024 Quarterly Editor in Chiefs
Subscribe Now for Free - eNL
Explore Our Conference Coverage
Subscribe for Free - Print
Stay Informed!
Don't miss the latest in dermatology news
2

Conference Coverage

View All
New Study Underscores High Economic and Comorbidity Burden for Patients with PN
New Study Underscores High Economic and Comorbidity Burden for Patients with PN

November 6th 2024

POLL: Are You Attending the Elevate-Derm West Conference?
POLL: Are You Attending the Elevate-Derm West Conference?

November 6th 2024

Off-Treatment Remission Achieved with Dupilumab for Pediatric AD
Off-Treatment Remission Achieved with Dupilumab for Pediatric AD

November 4th 2024

Rademikibart Differentiates From Dupilumab With Optimized IL-4Rα Inhibition and Enhanced Binding Stability
Rademikibart Differentiates From Dupilumab With Optimized IL-4Rα Inhibition and Enhanced Binding Stability

November 1st 2024

Latest Videos

All News

© 2024 MJH Life Sciences

All rights reserved.